supported by grants from the National Natural Science Foundation of China(No.81172826);Collaborative Innovation Center of Hematology,China
Acute graft-versus-host disease(a GVHD) is a serious complication after allogeneic hematopoietic stem cell transplantation(allo-HSCT). However,the mechanisms of a GVHD are not well understood. We aim to investigat...
supported by grants from the National Natural Science Foundation of China(No.81172826);Collaborative Innovation Center of Hematology,China
Summary: Although mesenchymal stem cells (MSCs) are increasingly used to treat graft-versus-host disease (GVHD), their immune regulatory mechanism in the process is elusive. The present study aimed to investigate...